Amanote Research
Register
Sign In
Inactivating BRAF Mutations Modulate RAS–MAPK Signaling
Cancer Discovery
- United States
doi 10.1158/2159-8290.cd-rw2017-153
Full Text
Open PDF
Abstract
Available in
full text
Categories
Oncology
Date
August 14, 2017
Authors
Unknown
Publisher
American Association for Cancer Research (AACR)
Related search
Selfish Mutations Dysregulating RAS-MAPK Signaling Are Pervasive in Aged Human Testes
Genome Research
Genetics
BRAF and RAS Mutations in Sporadic and Secondary Pyogenic Granuloma
Journal of Investigative Dermatology
Biochemistry
Dermatology
Cell Biology
Molecular Biology
Synaptic Plasticity, AMPA-R Trafficking, and Ras-Mapk Signaling
Acta Pharmacologica Sinica
Medicine
Pharmacology
Defect in MAPK Signaling as a Cause for Monogenic Obesity Caused by Inactivating Mutations in the Melanocortin-4 Receptor Gene
International Journal of Biological Sciences
Applied Microbiology
Evolution
Ecology
Developmental Biology
Cell Biology
Molecular Biology
Systematics
Behavior
Biotechnology
809 Pou4f1 Promotes Braf Inhibitor Resistance by Reactivating Mapk Signaling Pathway in Melanoma
Journal of Investigative Dermatology
Biochemistry
Dermatology
Cell Biology
Molecular Biology
Systemic Regulation of RAS/MAPK Signaling by the Serotonin Metabolite 5-Hiaa
PLoS Genetics
Evolution
Ecology
Genetics
Molecular Biology
Cancer Research
Systematics
Behavior
Down-Regulation of S100A9 Inhibits Osteosarcoma Cell Growth Through Inactivating MAPK and NF-κB Signaling Pathways
BMC Cancer
Cancer Research
Oncology
Genetics
Proteomic Analysis of Human T Cell-Derived Exosomes Reveals Differential RAS/MAPK Signaling
European Journal of Immunology
Allergy
Immunology
miR-34a Regulates Mesangial Cell Proliferation via the PDGFR-β/Ras-MAPK Signaling Pathway
Cellular and Molecular Life Sciences
Molecular Neuroscience
Molecular Medicine
Cell Biology
Molecular Biology
Pharmacology
Cellular